Vieth M, Kulig M, Leodolter A, Nauclér E, Jaspersen D, Labenz J, Meyer-Sabellek W, Lind T, Willich S, Malfertheiner P, Stolte M
Institute of Pathology, Klinikum Bayreuth, Bayreuth, Germany.
Aliment Pharmacol Ther. 2006 Jan 15;23(2):313-9. doi: 10.1111/j.1365-2036.2006.02752.x.
Proton pump inhibitor therapy has been reported to reduce proliferative changes of the oesophagus significantly in gastro-oesophageal reflux disease (GERD).
To assess the histological effects of esomeprazole treatment on the oesophagus.
Data were derived from a subgroup of patients participating in the proGERD study, who had either erosive reflux disease (n = 720) or non-erosive reflux disease (n = 35) and who had biopsy data from two sites [(i) 2 cm above the z-line and (ii) at the z-line], obtained at baseline and following treatment with esomeprazole. Proliferative changes of the squamous epithelium were assessed histologically by measuring thickness of the basal cell layer and elongation of the papillae as a percentage of the whole epithelial thickness.
In erosive reflux disease patients, the thickness of the basal cell layer and length of the papillae pretreatment were associated with the severity of oesophagitis (P < 0.05), at both biopsy sites. After esomeprazole treatment, baseline thickness and length of papillae were significantly reduced (P < 0.05) at both biopsy sites in non-erosive reflux disease and erosive reflux disease patients (particularly those with Los Angeles grades C and D).
This demonstrates a strong correlation between severity of GERD and histological parameters. Esomeprazole therapy resulted in clear reversal of proliferative changes observed prior to treatment in the squamous epithelium at both biopsy locations.
据报道,质子泵抑制剂疗法可显著减少胃食管反流病(GERD)患者食管的增殖性变化。
评估埃索美拉唑治疗对食管的组织学影响。
数据来自参与proGERD研究的患者亚组,这些患者患有糜烂性反流病(n = 720)或非糜烂性反流病(n = 35),并在基线时以及接受埃索美拉唑治疗后,从两个部位获取活检数据[(i)齿状线以上2 cm处和(ii)齿状线处]。通过测量基底细胞层厚度和乳头伸长占整个上皮厚度的百分比,对鳞状上皮的增殖性变化进行组织学评估。
在糜烂性反流病患者中,两个活检部位的基底细胞层厚度和乳头长度在预处理时均与食管炎严重程度相关(P < 0.05)。在非糜烂性反流病和糜烂性反流病患者(尤其是洛杉矶分级为C和D级的患者)中,埃索美拉唑治疗后,两个活检部位的乳头基线厚度和长度均显著降低(P < 0.05)。
这表明GERD严重程度与组织学参数之间存在密切相关性。埃索美拉唑治疗使两个活检部位鳞状上皮在治疗前观察到的增殖性变化明显逆转。